Clinical Data Launches Genetic Test For Hypertrophic Cardiomyopathy (HCM)

Clinical Data, Inc. (NASDAQ:CLDA) announced at the Heart Rhythm Society’s annual meeting, 2008 Heart Rhythm, that its PGxHealthTM division is adding genetic testing for Hypertrophic Cardiomyopathy (HCM) to its FAMILION® family of genetic tests for cardiac syndromes. “This new test emphasizes Clinical Data’s commitment to being the leader in advancing and marketing genetic tests for inherited cardiac conditions such as HCM,” said Drew Fromkin, President & CEO.

More: continued here

Filed under: Cardiovascular on May 22nd, 2008